ENT

  • Aspects of the Molecular Markers of Hemostatic Mechanism in Clinical Medicine

    Date:2015-10-23    Source:Greenovo
    The principle detemainants of thrombosis can be categorized in contemporary terms according to Virehow’s paradigm:abnormalities in endothehal function(vessel function),rheotogy(blood flow),or blood component, either alone or in combination,can promote thmmbus forma— tion.Among the blood components are included abnormalities in platelet function(primary hemostasis)
  • Biosurgery Market by Type, Application - Global Forecast to 2020

    Date:2015-10-20    Source:Greenovo
    The biosurgery market is majorly driven by the rising number of surgeries owing to the increasing rate of obesity and other lifestyle disorders, increasing participation in sports leading to sports-related injuries, and growing aging population However, lack of reimbursement for these products and the increasing cost of surgical procedures are expected to restrain the growth of this market during the forecast period
  • Noninvasive Hemostasis Pad

    Date:2015-10-20    Source:Greenovo
    Most interventional procedures are performed with 6 to 8F or larger sheaths and frequently involve anticoagulants,
  • vascular-access hemostasis system in anticoagulated patients undergoing interventional cardiac catheterization

    Date:2015-10-16    Source:Greenovo
    Evaluate the clinical utility of a poly-N-acetyl glucosamine vascular-access hemostasis system (SyvekEXCEL, Marine Polymer Technologies, Danvers, MA) after interventional cardiac catheterization
  • Biomaterials for Hemorrhage Control

    Date:2015-10-14    Source:Greenovo
    IntroductionIdeal hemostatic materials should have following characteristics (3, 26): quick and effective control of
GREENOVO. China
EMAIL:sales@gnovo.cn
Address:B9-3, Hi-Tech
Medical Device Park
Wuhan 430206
China.
Tel: +86 27 87880126
Fax: +86 27 87880126